Related Experiment Video
Updated: May 31, 2025

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells
Published on: June 3, 2012
TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses
Gilmara Barros de Lima1, Everton Nencioni1, Fábio Thimoteo1
1Graduate Program of Biosystems, Centro de Ciências Naturais e Humanas, Universidade Federal do ABC (UFABC), São Bernardo do Campo, São Paulo 09606-045, Brazil.
Abstract:
TMPRSS2, a human transmembrane protease enzyme, plays a crucial role in the spread of certain viruses, including influenza and coronaviruses. This enzyme promotes viral infection by cleaving viral glycoproteins, which helps viruses like SARS-CoV-2 and influenza A enter cells more effectively. Genetic differences in TMPRSS2 may affect people's susceptibility to COVID-19, underscoring the need for studies that consider diverse populations. Beyond infectious diseases, TMPRSS2 has also been linked to some cancers, suggesting it could be a valuable target for drug development. This review provides a summary of TMPRSS2 inhibitors currently under study, with some already in clinical trials to test their effectiveness against viral infections. As we uncover more about TMPRSS2's role in pathogenesis, it could open new doors for therapies to combat future outbreaks.
Insights
Transmembrane serine protease 2 (TMPRSS2) aids viral entry and infection. Inhibitors targeting TMPRSS2 show promise for treating viral diseases like COVID-19 and potentially cancers.
Area of Science:
- Biochemistry
- Virology
- Drug Discovery
Background:
- TMPRSS2 is a human enzyme critical for the spread of viruses like influenza and coronaviruses.
- It facilitates viral entry into host cells by cleaving viral glycoproteins, essential for pathogens such as SARS-CoV-2.
- Genetic variations in TMPRSS2 influence susceptibility to infections like COVID-19, highlighting the importance of population diversity in research.
Purpose of the Study:
- To review current TMPRSS2 inhibitors under investigation.
- To explore the therapeutic potential of targeting TMPRSS2 in viral infections and cancer.
Main Methods:
- Literature review of existing studies on TMPRSS2.
- Analysis of ongoing clinical trials for TMPRSS2 inhibitors.
Main Results:
- Several TMPRSS2 inhibitors are under investigation, with some progressing to clinical trials.
- TMPRSS2's dual role in viral pathogenesis and cancer suggests broad therapeutic applicability.
Conclusions:
- Targeting TMPRSS2 presents a promising strategy for developing novel antiviral therapies.
- Further research into TMPRSS2's role in disease could lead to new treatments for infectious diseases and cancer.
Related Concept Videos
Leaky Scanning
Viral Recombination

